Gut microbiota-derived TNF-α triggers dopaminergic neuron ferroptosis via TNFR1-NF-κB-ATF4 axis in Parkinson's disease.
7 affiliations
- 1Department of Hematology, South China Hospital of Shenzhen University, Shenzhen, Guangdong, PR China.
- 2Department of Neurosurgery, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong, PR China.
- 3Department of Neurosurgery, Peking University Shenzhen Hospital, Shenzhen, Guangdong, PR China.
- 4Department of Neurosurgery, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong, PR China. [email protected].
- 5Department of Neurosurgery, Peking University Shenzhen Hospital, Shenzhen, Guangdong, PR China. [email protected].
- 6Department of Neurosurgery, Peking University Shenzhen Hospital, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, Guangdong, PR China. [email protected].
- 7Department of Neurosurgery, Peking University Shenzhen Hospital, Shenzhen, Guangdong, PR China. [email protected].
Abstract
Parkinson's disease (PD) pathogenesis remains incompletely understood, with the causal link between gut microbiota dysbiosis and central neurodegeneration unclarified. This study aimed to unravel this complex interplay by integrating Mendelian randomization (MR) analysis, animal models, cellular experiments, and transcriptomic profiling. MR analysis identified Clostridium sensu stricto 1 and Candidatus Soleaferrea as novel genetic risk factors for PD, providing causal evidence for gut microbiota-driven PD pathogenesis. Using a chronic MPTP-induced PD mouse model, we confirmed that gut microbiota dysbiosis is accompanied by elevated tumor necrosis factor-α (TNF-α) in the intestine, plasma, and midbrain, along with dopaminergic neuron loss and motor deficits. Fecal microbiota transplantation (FMT) from healthy mice reversed these phenotypes, restoring gut homeostasis, reducing TNF-α levels, and preserving dopaminergic neurons. Transcriptomic analysis of mouse midbrain and human PD substantia nigra (GEO datasets) revealed ferroptosis as a key enriched pathway, with activating transcription factor 4 (ATF4) significantly upregulated in both PD models and patients. Mechanistically, TNF-α induced ATF4 overexpression in a concentration- and time-dependent manner, triggering dopaminergic neuron ferroptosis. This effect was mediated by TNF-α binding to TNFR1 (not TNFR2), activating the NF-κB pathway, and subsequently upregulating ATF4. Knockdown of ATF4 or inhibition of NF-κB reversed TNF-α-induced ferroptosis, as evidenced by restored glutathione (GSH) levels, reduced malondialdehyde (MDA) accumulation, and improved cell viability. Our findings establish a novel gut-brain axis-mediated pathogenic pathway: gut microbiota dysbiosis drives TNF-α-TNFR1-NF-κB-ATF4 signaling, leading to dopaminergic neuron ferroptosis and PD progression. This study bridges the gap between peripheral microbial dysbiosis and central neurodegeneration, identifies potential therapeutic targets, and highlights FMT as a promising intervention for PD.
Related
- Dopamine Metabolism as a Chemically Constrained Network: Structural Regulation, Redox Liability and Dopaminergic Vulnerability in Parkinson’s Disease
- Microglial Foxo3 shapes dopaminergic vulnerability in Parkinson’s disease
- Targeting host ferroptosis in cancer cachexia: Tumor-immune triggers, tissue wasting, and the therapeutic paradox
- Targeting asparagine synthetase triggers ferroptosis and suppresses endometrial cancer growth via Atractylenolide II
- 4-Methoxydalbergione triggers ferroptosis in bladder cancer by suppressing the AKT/mTOR/GPX4 axis
BibTeX
@article{zhang2026microbiotaderived,
title = {{Gut microbiota-derived TNF-α triggers dopaminergic neuron ferroptosis via TNFR1-NF-κB-ATF4 axis in Parkinson's disease.}},
author = {Zixia Zhang and Sufang Zhong and Liangliang Gao and Baodong Chen and Peng Huang},
journal = {Cell death discovery},
year = {2026},
month = aug,
doi = {10.1038/s41420-026-03281-x},
url = {https://europepmc.org/article/MED/42957631},
note = {CC BY},
}
RIS
TY - JOUR
TI - Gut microbiota-derived TNF-α triggers dopaminergic neuron ferroptosis via TNFR1-NF-κB-ATF4 axis in Parkinson's disease.
AU - Zixia Zhang
AU - Sufang Zhong
AU - Liangliang Gao
AU - Baodong Chen
AU - Peng Huang
PY - 2026
DA - 2026/08/01
JO - Cell death discovery
DO - 10.1038/s41420-026-03281-x
UR - https://europepmc.org/article/MED/42957631
AB - Parkinson's disease (PD) pathogenesis remains incompletely understood, with the causal link between gut microbiota dysbiosis and central neurodegeneration unclarified. This study aimed to unravel this complex interplay by integrating Mendelian randomization (MR) analysis, animal models, cellular experiments, and transcriptomic profiling. MR analysis identified Clostridium sensu stricto 1 and Candidatus Soleaferrea as novel genetic risk factors for PD, providing causal evidence for gut microbiota-driven PD pathogenesis. Using a chronic MPTP-induced PD mouse model, we confirmed that gut microbiota dysbiosis is accompanied by elevated tumor necrosis factor-α (TNF-α) in the intestine, plasma, and midbrain, along with dopaminergic neuron loss and motor deficits. Fecal microbiota transplantation (FMT) from healthy mice reversed these phenotypes, restoring gut homeostasis, reducing TNF-α levels, and preserving dopaminergic neurons. Transcriptomic analysis of mouse midbrain and human PD substantia nigra (GEO datasets) revealed ferroptosis as a key enriched pathway, with activating transcription factor 4 (ATF4) significantly upregulated in both PD models and patients. Mechanistically, TNF-α induced ATF4 overexpression in a concentration- and time-dependent manner, triggering dopaminergic neuron ferroptosis. This effect was mediated by TNF-α binding to TNFR1 (not TNFR2), activating the NF-κB pathway, and subsequently upregulating ATF4. Knockdown of ATF4 or inhibition of NF-κB reversed TNF-α-induced ferroptosis, as evidenced by restored glutathione (GSH) levels, reduced malondialdehyde (MDA) accumulation, and improved cell viability. Our findings establish a novel gut-brain axis-mediated pathogenic pathway: gut microbiota dysbiosis drives TNF-α-TNFR1-NF-κB-ATF4 signaling, leading to dopaminergic neuron ferroptosis and PD progression. This study bridges the gap between peripheral microbial dysbiosis and central neurodegeneration, identifies potential therapeutic targets, and highlights FMT as a promising intervention for PD.
SN - 2058-7716
ER -